 | • レポートコード：GIR-2104Z07443 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、イマチニブ薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。イマチニブ薬の種類別市場規模（錠剤、カプセル）、用途別市場規模（慢性骨髄性白血病、消化管間質腫瘍、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・イマチニブ薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis、Glenmark Pharmaceuticals Ltd.、Sun Pharmaceuticals、Actavis Generics、Dr. Reddy's Laboratories、Teva Pharmaceutical Industries Ltd.、Sanofi S.A.、Cipla Inc.、Apotex Inc.、Mylan Pharms Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：錠剤、カプセル ・用途別分析2016年-2026年：慢性骨髄性白血病、消化管間質腫瘍、その他 ・イマチニブ薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・イマチニブ薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・イマチニブ薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・イマチニブ薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・イマチニブ薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Imatinib Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Imatinib Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Imatinib Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Imatinib Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablets
Capsules
Market segment by Application can be divided into
Chronic Myelogenous Leukemia
Gastrointestinal Stromal Tumors
Others
The key market players for global Imatinib Drug market are listed below:
Novartis
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy’s Laboratories
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Cipla Inc.
Apotex Inc.
Mylan Pharms Inc.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Imatinib Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Imatinib Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tablets
1.2.3 Capsules
1.3 Market Analysis by Application
1.3.1 Overview: Global Imatinib Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Chronic Myelogenous Leukemia
1.3.3 Gastrointestinal Stromal Tumors
1.3.4 Others
1.4 Global Imatinib Drug Market Size & Forecast
1.4.1 Global Imatinib Drug Sales in Value (2016-2026))
1.4.2 Global Imatinib Drug Sales in Volume (2016-2026)
1.4.3 Global Imatinib Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Imatinib Drug Production Capacity Analysis
1.5.1 Global Imatinib Drug Total Production Capacity (2016-2026)
1.5.2 Global Imatinib Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Imatinib Drug Market Drivers
1.6.2 Imatinib Drug Market Restraints
1.6.3 Imatinib Drug Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Imatinib Drug Product and Services
2.1.4 Novartis Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Glenmark Pharmaceuticals Ltd.
2.2.1 Glenmark Pharmaceuticals Ltd. Details
2.2.2 Glenmark Pharmaceuticals Ltd. Major Business
2.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product and Services
2.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Sun Pharmaceuticals
2.3.1 Sun Pharmaceuticals Details
2.3.2 Sun Pharmaceuticals Major Business
2.3.3 Sun Pharmaceuticals Imatinib Drug Product and Services
2.3.4 Sun Pharmaceuticals Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Actavis Generics
2.4.1 Actavis Generics Details
2.4.2 Actavis Generics Major Business
2.4.3 Actavis Generics Imatinib Drug Product and Services
2.4.4 Actavis Generics Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Dr. Reddy’s Laboratories
2.5.1 Dr. Reddy’s Laboratories Details
2.5.2 Dr. Reddy’s Laboratories Major Business
2.5.3 Dr. Reddy’s Laboratories Imatinib Drug Product and Services
2.5.4 Dr. Reddy’s Laboratories Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Teva Pharmaceutical Industries Ltd.
2.6.1 Teva Pharmaceutical Industries Ltd. Details
2.6.2 Teva Pharmaceutical Industries Ltd. Major Business
2.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product and Services
2.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Sanofi S.A.
2.7.1 Sanofi S.A. Details
2.7.2 Sanofi S.A. Major Business
2.7.3 Sanofi S.A. Imatinib Drug Product and Services
2.7.4 Sanofi S.A. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Cipla Inc.
2.8.1 Cipla Inc. Details
2.8.2 Cipla Inc. Major Business
2.8.3 Cipla Inc. Imatinib Drug Product and Services
2.8.4 Cipla Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Apotex Inc.
2.9.1 Apotex Inc. Details
2.9.2 Apotex Inc. Major Business
2.9.3 Apotex Inc. Imatinib Drug Product and Services
2.9.4 Apotex Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Mylan Pharms Inc.
2.10.1 Mylan Pharms Inc. Details
2.10.2 Mylan Pharms Inc. Major Business
2.10.3 Mylan Pharms Inc. Imatinib Drug Product and Services
2.10.4 Mylan Pharms Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Imatinib Drug Sales by Manufacturer
3.1 Global Imatinib Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Imatinib Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Imatinib Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Imatinib Drug Manufacturer Market Share
3.4.2 Top 6 Imatinib Drug Manufacturer Market Share
3.5 Global Imatinib Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Imatinib Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Imatinib Drug Market Size by Region
4.1.1 Global Imatinib Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Imatinib Drug Revenue by Region (2016-2026)
4.2 North America Imatinib Drug Revenue (2016-2026)
4.3 Europe Imatinib Drug Revenue (2016-2026)
4.4 Asia-Pacific Imatinib Drug Revenue (2016-2026)
4.5 South America Imatinib Drug Revenue (2016-2026)
4.6 Middle East and Africa Imatinib Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Imatinib Drug Sales in Volume by Type (2016-2026)
5.2 Global Imatinib Drug Revenue by Type (2016-2026)
5.3 Global Imatinib Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Imatinib Drug Sales in Volume by Application (2016-2026)
6.2 Global Imatinib Drug Revenue by Application (2016-2026)
6.3 Global Imatinib Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Imatinib Drug Sales by Type (2016-2026)
7.2 North America Imatinib Drug Sales by Application (2016-2026)
7.3 North America Imatinib Drug Market Size by Country
7.3.1 North America Imatinib Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Imatinib Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Imatinib Drug Sales by Type (2016-2026)
8.2 Europe Imatinib Drug Sales by Application (2016-2026)
8.3 Europe Imatinib Drug Market Size by Country
8.3.1 Europe Imatinib Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Imatinib Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Imatinib Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Imatinib Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Imatinib Drug Market Size by Region
9.3.1 Asia-Pacific Imatinib Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Imatinib Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Imatinib Drug Sales by Type (2016-2026)
10.2 South America Imatinib Drug Sales by Application (2016-2026)
10.3 South America Imatinib Drug Market Size by Country
10.3.1 South America Imatinib Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Imatinib Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Imatinib Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Imatinib Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Imatinib Drug Market Size by Country
11.3.1 Middle East & Africa Imatinib Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Imatinib Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Imatinib Drug Typical Distributors
12.3 Imatinib Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Imatinib Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Imatinib Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Imatinib Drug Product and Services
Table 6. Novartis Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Glenmark Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 8. Glenmark Pharmaceuticals Ltd. Major Business
Table 9. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product and Services
Table 10. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Sun Pharmaceuticals Major Business
Table 13. Sun Pharmaceuticals Imatinib Drug Product and Services
Table 14. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Actavis Generics Basic Information, Manufacturing Base and Competitors
Table 16. Actavis Generics Major Business
Table 17. Actavis Generics Imatinib Drug Product and Services
Table 18. Actavis Generics Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 20. Dr. Reddy's Laboratories Major Business
Table 21. Dr. Reddy's Laboratories Imatinib Drug Product and Services
Table 22. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Industries Ltd. Major Business
Table 25. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product and Services
Table 26. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi S.A. Major Business
Table 29. Sanofi S.A. Imatinib Drug Product and Services
Table 30. Sanofi S.A. Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Cipla Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Cipla Inc. Major Business
Table 33. Cipla Inc. Imatinib Drug Product and Services
Table 34. Cipla Inc. Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Apotex Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Apotex Inc. Major Business
Table 37. Apotex Inc. Imatinib Drug Product and Services
Table 38. Apotex Inc. Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Mylan Pharms Inc. Basic Information, Manufacturing Base and Competitors
Table 40. Mylan Pharms Inc. Major Business
Table 41. Mylan Pharms Inc. Imatinib Drug Product and Services
Table 42. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Imatinib Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Imatinib Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Imatinib Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Imatinib Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Imatinib Drug Production Site of Key Manufacturer
Table 48. Global Imatinib Drug Sales by Region (2016-2021e) & (K Units)
Table 49. Global Imatinib Drug Sales by Region (2021-2026) & (K Units)
Table 50. Global Imatinib Drug Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Imatinib Drug Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Imatinib Drug Sales by Type (2016-2021e) & (K Units)
Table 53. Global Imatinib Drug Sales by Type (2021-2026) & (K Units)
Table 54. Global Imatinib Drug Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Imatinib Drug Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Imatinib Drug Price by Type (2016-2021e) & (USD/Unit)
Table 57. Global Imatinib Drug Price by Type (2021-2026) & (USD/Unit)
Table 58. Global Imatinib Drug Sales by Application (2016-2021e) & (K Units)
Table 59. Global Imatinib Drug Sales by Application (2021-2026) & (K Units)
Table 60. Global Imatinib Drug Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Imatinib Drug Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Imatinib Drug Price by Application (2016-2021e) & (USD/Unit)
Table 63. Global Imatinib Drug Price by Application (2021-2026) & (USD/Unit)
Table 64. North America Imatinib Drug Sales by Country (2016-2021e) & (K Units)
Table 65. North America Imatinib Drug Sales by Country (2021-2026) & (K Units)
Table 66. North America Imatinib Drug Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Imatinib Drug Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Imatinib Drug Sales by Type (2016-2021e) & (K Units)
Table 69. North America Imatinib Drug Sales by Type (2021-2026) & (K Units)
Table 70. North America Imatinib Drug Sales by Application (2016-2021e) & (K Units)
Table 71. North America Imatinib Drug Sales by Application (2021-2026) & (K Units)
Table 72. Europe Imatinib Drug Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Imatinib Drug Sales by Country (2021-2026) & (K Units)
Table 74. Europe Imatinib Drug Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Imatinib Drug Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Imatinib Drug Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Imatinib Drug Sales by Type (2021-2026) & (K Units)
Table 78. Europe Imatinib Drug Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Imatinib Drug Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Imatinib Drug Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Imatinib Drug Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Imatinib Drug Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Imatinib Drug Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Imatinib Drug Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Imatinib Drug Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Imatinib Drug Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Imatinib Drug Sales by Application (2021-2026) & (K Units)
Table 88. South America Imatinib Drug Sales by Country (2016-2021e) & (K Units)
Table 89. South America Imatinib Drug Sales by Country (2021-2026) & (K Units)
Table 90. South America Imatinib Drug Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Imatinib Drug Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Imatinib Drug Sales by Type (2016-2021e) & (K Units)
Table 93. South America Imatinib Drug Sales by Type (2021-2026) & (K Units)
Table 94. South America Imatinib Drug Sales by Application (2016-2021e) & (K Units)
Table 95. South America Imatinib Drug Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Imatinib Drug Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Imatinib Drug Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Imatinib Drug Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Imatinib Drug Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Imatinib Drug Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Imatinib Drug Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Imatinib Drug Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Imatinib Drug Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Imatinib Drug Typical Distributors
Table 107. Imatinib Drug Typical Customers
List of Figures
Figure 1. Imatinib Drug Picture
Figure 2. Global Imatinib Drug Sales Market Share by Type in 2020
Figure 3. Tablets
Figure 4. Capsules
Figure 5. Global Imatinib Drug Sales Market Share by Application in 2020
Figure 6. Chronic Myelogenous Leukemia
Figure 7. Gastrointestinal Stromal Tumors
Figure 8. Others
Figure 9. Global Imatinib Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Imatinib Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Imatinib Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Imatinib Drug Sales (2016-2026) & (K Units)
Figure 31. Global Imatinib Drug Production Capacity (2016-2026) & (K Units)
Figure 32. Global Imatinib Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Imatinib Drug Market Drivers
Figure 34. Imatinib Drug Market Restraints
Figure 35. Imatinib Drug Market Trends
Figure 36. Global Imatinib Drug Sales Market Share by Manufacturer in 2020
Figure 37. Global Imatinib Drug Revenue Market Share by Manufacturer in 2020
Figure 38. Imatinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Imatinib Drug Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Imatinib Drug Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Imatinib Drug Sales Market Share by Region (2016-2026)
Figure 42. Global Imatinib Drug Revenue Market Share by Region (2016-2026)
Figure 43. North America Imatinib Drug Revenue (2016-2026) & (USD Million)
Figure 44. Europe Imatinib Drug Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Imatinib Drug Revenue (2016-2026) & (USD Million)
Figure 46. South America Imatinib Drug Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Imatinib Drug Revenue (2016-2026) & (USD Million)
Figure 48. Global Imatinib Drug Sales Market Share by Type (2016-2026)
Figure 49. Global Imatinib Drug Revenue Market Share by Type (2016-2026)
Figure 50. Global Imatinib Drug Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Imatinib Drug Sales Market Share by Application (2016-2026)
Figure 52. Global Imatinib Drug Revenue Market Share by Application (2016-2026)
Figure 53. Global Imatinib Drug Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Imatinib Drug Sales Market Share by Country (2016-2026)
Figure 55. North America Imatinib Drug Revenue Market Share by Country (2016-2026)
Figure 56. North America Imatinib Drug Sales Market Share by Type (2016-2026)
Figure 57. North America Imatinib Drug Sales Market Share by Application (2016-2026)
Figure 58. Europe Imatinib Drug Sales Market Share by Country (2016-2026)
Figure 59. Europe Imatinib Drug Revenue Market Share by Country (2016-2026)
Figure 60. Europe Imatinib Drug Sales Market Share by Type (2016-2026)
Figure 61. Europe Imatinib Drug Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Imatinib Drug Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Imatinib Drug Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Imatinib Drug Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Imatinib Drug Sales Market Share by Application (2016-2026)
Figure 66. South America Imatinib Drug Sales Market Share by Country (2016-2026)
Figure 67. South America Imatinib Drug Revenue Market Share by Country (2016-2026)
Figure 68. South America Imatinib Drug Sales Market Share by Type (2016-2026)
Figure 69. South America Imatinib Drug Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Imatinib Drug Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Imatinib Drug Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Imatinib Drug Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Imatinib Drug Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のメシル酸イマチニブ薬市場 2021：企業別、地域別、種類・用途別 The Imatinib Mesylate Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…- 世界のメシル酸イマチニブ市場 2021：企業別、地域別、種類・用途別 The Imatinib Mesylate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 世界のフルバスタチンナトリウム薬市場 2021：企業別、地域別、種類・用途別 The Fluvastatin Sodium Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の消化管間質腫瘍（GIST）治療市場規模・現状・予測（2021年-2027年） A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine. Market Analysis and Insights: Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market The global Gastrointestinal Stromal Tumors (GISTs) …
- 世界の小売薬市場規模・現状・予測（2021年-2027年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…